Order Article Reprints

Wang J, Wang F, Xie D, Zhou M, Liao J, Wu H, Dai Y, Huang J, Zhao Y. PLGA Nanoparticles Containing VCAM-1 Inhibitor Succinobucol and Chemotherapeutic Doxorubicin as Therapy against Primary Tumors and Their Lung Metastases. Pharmaceutics. 2023; 15(2):349. https://doi.org/10.3390/pharmaceutics15020349

Wang, Jie, Fengling Wang, Dandan Xie, Min Zhou, Jiaxing Liao, Hongliang Wu, Yue Dai, Jingbin Huang, and Yu Zhao. 2023. "PLGA Nanoparticles Containing VCAM-1 Inhibitor Succinobucol and Chemotherapeutic Doxorubicin as Therapy against Primary Tumors and Their Lung Metastases" Pharmaceutics 15, no. 2: 349. https://doi.org/10.3390/pharmaceutics15020349

Wang, J., Wang, F., Xie, D., Zhou, M., Liao, J., Wu, H., Dai, Y., Huang, J., & Zhao, Y. (2023). PLGA Nanoparticles Containing VCAM-1 Inhibitor Succinobucol and Chemotherapeutic Doxorubicin as Therapy against Primary Tumors and Their Lung Metastases. Pharmaceutics, 15(2), 349. https://doi.org/10.3390/pharmaceutics15020349